announcing discovery of Covid-19 treatment by using revolutionary genetic predictive models

ID: 1564261
recent pressrelease next pressrelease

(businesspress24) - Potsdam, Germany:, a Potsdam, Germany based genetic analytics start-up today announced the discovery of the direct impacts of cyclin-dependent kinase 6 (CDK6) and neutrophils on patients with severe COVID-19.’s scientists simulated the severe COVID-19 phenotype in genomic data with its proprietary AI prediction platform in order to find gene variants that influence the disease outcome.

“Currently investigated immune blockers had only weak signals in our simulation whereas CDK6 inhibitors showed strong causal effects to prevent lung thromboinflammation, the main deadly outcome of severe COVID-19. I am very proud of the team. Our aim is to contribute to better and faster treatment of patients during this global pandemic using novel statistical tools for genomics.” said Dr. Joern Klinger, CEO and co-founder.

Patients can now expect a much faster availability of COVID-19 treatments by utilizing three repurposed and already regulatory approved drugs, which were developed by three global pharmaceutical companies to medicate breast cancer successfully. will continue to work with research organizations across the globe using the unique platform and applying its library, drug target linkage and diagnostics solutions.

More information:

Keywords (optional):

biotx-ai, covid, 19, treatment, cdk6,

Company information / Profile:

PressRelease by

published by: RealWire
print pressrelease  pressrelease as PDF  send to a friend  

Date: 02/02/2021 - 07:31
Language: English
News-ID 1564261
Character count: 1343
Firma: RealWire
Ansprechpartner: Courtney Dean Feedback to about Pressrelease-id:
Stadt: Lincoln
Telefon: 01522 883 640

Meldungsart: bitte
Versandart: Veröffentlichung

Number of hits: 225


Direct Link to this PressRelease:

We would appreciate a link in your News-, Press- or Partner-Site.

Comments on this PressRelease

All members: 9 438
Register today: 0
Register yesterday: 0
Members online: 0
Guests online: 74

Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.